BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 29016672)

  • 1. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lupeol on antioxidants and xenobiotic enzymes in N-Butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
    Prabhu B; Sivakumar A; Balakrishnan D; Sundaresan S
    J Exp Ther Oncol; 2017 Sep; 11(2):139-416. PubMed ID: 28976137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of glutathione S-transferase M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse bladder carcinogenesis.
    Chuang JJ; Dai YC; Lin YL; Chen YY; Lin WH; Chan HL; Liu YW
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):322-330. PubMed ID: 24998975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inorganic arsenic in drinking water accelerates N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tissue damage in mice.
    Lin PY; Lin YL; Huang CC; Chen SS; Liu YW
    Toxicol Appl Pharmacol; 2012 Feb; 259(1):27-37. PubMed ID: 22178741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine as the basis for urothelial carcinogenesis.
    He Z; Kosinska W; Zhao ZL; Wu XR; Guttenplan JB
    Mutat Res; 2012 Feb; 742(1-2):92-5. PubMed ID: 22155125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of uroplakin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats and mice.
    Ogawa K; St John M; Luiza de Oliveira M; Arnold L; Shirai T; Sun TT; Cohen SM
    Toxicol Pathol; 1999; 27(6):645-51. PubMed ID: 10588545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on "tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine as the basis for urothelial cell carcinogenesis." He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB, Department of Basic Science, New York University Dental College, NY, USA.: Mutat Res 2012;742(1-2):92-5 [Epub 2011 Dec 4].
    Scherr DS
    Urol Oncol; 2014 Feb; 32(2):214. PubMed ID: 24445298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of p27 kip1 knockout mice to urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine may not simply be due to enhanced proliferation.
    Hikosaka A; Ogawa K; Sugiura S; Asamoto M; Takeshita F; Sato SY; Nakanishi M; Kohri K; Shirai T
    Int J Cancer; 2008 Mar; 122(6):1222-8. PubMed ID: 18027869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice.
    Kondo Y; Himeno S; Endo W; Mita M; Suzuki Y; Nemoto K; Akimoto M; Lazo JS; Imura N
    Carcinogenesis; 1999 Aug; 20(8):1625-7. PubMed ID: 10426817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
    Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
    Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
    Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats.
    Xie XL; Gi M; Fujioka M; Doi K; Yamano S; Tachibana H; Fang H; Kakehashi A; Wanibuchi H
    Food Chem Toxicol; 2015 Sep; 83():193-200. PubMed ID: 26111810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
    Wakui S; Mutou T; Takahashi H; Ikegami M; Wanibuchi H; Fukushima S
    J Appl Toxicol; 2015 Feb; 35(2):181-90. PubMed ID: 24888239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of zinc and metallothionein in the rat bladder epithelium during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Zhang XH; Jin L; Takenaka I
    Urol Res; 1996; 24(5):279-83. PubMed ID: 8931292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation adduct formation and H-ras gene mutations in progression of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder tumors caused by a single exposure to N-methyl-N-nitrosourea.
    Shibata MA; Shirai T; Ogawa K; Takahashi S; Wild CP; Montesano R; Tsuda H; Ito N
    Carcinogenesis; 1994 Dec; 15(12):2965-8. PubMed ID: 8001265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
    Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
    Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Vinh PQ; Sugie S; Tanaka T; Hara A; Yamada Y; Katayama M; Deguchi T; Mori H
    Jpn J Cancer Res; 2002 Jan; 93(1):42-9. PubMed ID: 11802807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effect of 1,4-phenylene diisothiocyanate on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Sugie S; Vinh PQ; Rahman KM; Ushida J; Kohno H; Suzuki R; Hara A; Quang le B; Tanaka T; Mori H
    Int J Cancer; 2005 Nov; 117(4):524-30. PubMed ID: 15929075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
    Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
    Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promotion effects of acetoaceto-o-toluidide on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.
    Yukimatsu N; Gi M; Okuno T; Fujioka M; Suzuki S; Kakehashi A; Yanagiba Y; Suda M; Koda S; Nakatani T; Wanibuchi H
    Arch Toxicol; 2019 Dec; 93(12):3617-3631. PubMed ID: 31673724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.